“Psychedelic Use in Canada; Results of the Canadian Psychedelic Survey”.

Philippe Lucas PhD is a cannabis and psychedelic researcher and President of SABI Mind, a clinic group providing access to psychedelic-assisted therapy in the treatment of mental health, pain and problematic substance use. Philippe was founder and Executive Director of the Vancouver Island Compassion Society, one of Canada’s first medical cannabis dispensaries, a founding Board member of the Multidisciplinary Association of Psychedelic Studies Canada, and co-founder of the Victoria Association of Psychedelic Studies. More recently he worked as VP, Global Patient Research & Access at Tilray, where he oversaw a comprehensive international clinical and observational cannabis research program, and he is also acting-CEO of Compassionate Analytics, which produces on-site analytical tools for the cannabis industry.

He has received a number of accolades for his patient research and advocacy, including the Americans for Safe Access Researcher of the Year Award 2021, the Cannabis Council of Canada Lifetime Achievement Award, and the Queen Elizabeth II Diamond Jubilee Medal.